U-Chart Analysis:Daito Pharmaceutical Co.,Ltd.:4577

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Daito Pharmaceutical Co.,Ltd. Go to web site 4577 Medicals 東証プライム May 1, 2000 2010.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Daito Pharmaceutical Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Daito Pharmaceutical Co.,Ltd. Balance Sheet 2024年5月期 Daito Pharmaceutical Co.,Ltd. Balance Sheet 2023年5月期 Daito Pharmaceutical Co.,Ltd. Balance Sheet 2022年5月期 Daito Pharmaceutical Co.,Ltd. Balance Sheet 2021年5月期 Daito Pharmaceutical Co.,Ltd. Balance Sheet 2020年5月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date May 31, 2024 May 31, 2023 May 31, 2022 May 31, 2021 May 31, 2020
Cash and Cash Equivalents 2,727 3,607 4,381 3,373 3,084
Other Current AssetsHelp 38,733 37,056 33,528 29,057 27,771
Tangible Fixed AssetsHelp 31,972 25,837 23,116 21,372 19,400
Intangible Fixed AssetHelp 490 377 386 333 299
Investments and OthersHelp 3,786 3,675 3,528 3,605 3,696
Total AssetsHelp 77,708 70,552 64,939 57,739 54,250
Total Current LiabilitiesHelp 19,294 16,435 15,385 14,102 16,158
Total Long-term LiabilitiesHelp 6,345 3,445 2,247 2,019 1,583
Shareholder's EquityHelp 52,069 50,672 47,307 41,619 36,509
Total LiabilitiesHelp 77,708 70,552 64,939 57,739 54,250

Daito Pharmaceutical Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2024年5月期 Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2023年5月期 Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2022年5月期 Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2021年5月期 Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2020年5月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date May 31, 2024 May 31, 2023 May 31, 2022 May 31, 2021 May 31, 2020
Amount of Sales 46,895 45,101 43,464 48,715 44,991
Total Sales 46,895 45,101 43,464 48,715 44,991
Cost of SalesHelp 37,056 34,770 32,005 37,917 35,513
Other Costs and RevenueHelp 6,545 6,732 6,791 6,551 5,534
Total CostsHelp 43,601 41,502 38,796 44,469 41,047
Net RevenueHelp 9,839 10,331 11,459 10,798 9,479
Earnings Before TaxHelp 4,218 5,076 6,720 5,874 5,595
Net IncomeHelp 3,294 3,599 4,668 4,246 3,945
Net Income 3,294 3,599 4,668 4,246 3,945

Daito Pharmaceutical Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2024年5月期 Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2023年5月期 Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2022年5月期 Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2021年5月期 Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2020年5月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date May 31, 2024 May 31, 2023 May 31, 2022 May 31, 2021 May 31, 2020
Operating Cash Flow(OFC)Help 5,183 4,156 4,371 5,183 4,306
Investing Cash Flow(ICF)Help -5,930 -5,566 -4,400 -6,324 -2,681
Financing Cash FlowHelp -183 616 989 1,425 -350
Exchange Difference of Cash and Cash EquivalentsHelp 51 20 48 6 -10
Net Increase and Decrease in Cash and Cash Equivalentsn -879 -774 1,008 289 1,265

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Daito Pharmaceutical Co.,Ltd.

Company where related level is highHelp

DENKA SEIKEN Co.,Ltd.
PeptiDream Inc.
MEDICAL & BIOLOGICAL LABORATORIES CO.
ASKA Pharmaceutical Co.,Ltd.
D.Western Therapeutics Institute, Inc.
NIPPON CHEMIPHAR CO.,LTD.
LTT Bio-Pharma Co.,Ltd.
Tsubota Laboratory Incorporated
Cuorips Inc.
Renascience Inc.